Movano Health Receives Nasdaq Deficiency Notification for 10-Q Filing Delay

On May 23, 2025, Movano Health (Nasdaq: MOVE) announced a critical situation regarding its compliance with Nasdaq's listing requirements. The company received an official notice from the Nasdaq Listing Qualifications Department, indicating that it had failed to file its quarterly report on Form 10-Q for the period ending March 31, 2025, by the designated due date of May 15, 2025. This delay puts Movano Health in violation of Nasdaq Listing Rule 5250(c)(1), which mandates that all periodic financial reports must be filed promptly with the Securities and Exchange Commission (SEC).

As a result of this non-compliance, Movano Health has been granted a 60-day period, until July 21, 2025, to submit a plan outlining how it intends to rectify this situation and regain compliance with Nasdaq rules. Should Nasdaq accept the company's proposed plan, it may offer Movano Health up to an additional 180 days, extending the deadline for the submission of the overdue Form 10-Q to November 11, 2025.

In the event that Nasdaq does not accept their compliance plan, Movano Health will have the right to appeal the decision to a Nasdaq Hearings Panel. The company remains committed to addressing this deficiency and has stated its intentions to work diligently to resolve the matter.

Founded in 2018, Movano Health focuses on delivering advanced healthcare solutions that harness medical-grade data through wearable technology. Their mission is to provide comprehensive health data to both consumers and enterprises, effectively translating this information into valuable insights that can enhance health outcomes. The innovative wearable devices from Movano Health are designed with modern aesthetics, combining functionality with style to meet the needs of users seeking health monitoring tools.

The company emphasizes the importance of data in healthcare management, seeking to empower individuals across various patient demographics by equipping them with relevant health information. With a commitment to improving health outcomes, Movano Health aims to leverage its proprietary technologies and devices to revolutionize health monitoring practices.

As the company navigates this recent notification from Nasdaq, it is crucial for stakeholders to remain informed about potential developments. Movano Health's forward-looking statements acknowledge the uncertainty surrounding regulatory compliance and the timeline for addressing the filing delays. The company urges caution regarding the reliability of such statements, as external factors may significantly influence their ability to meet Nasdaq's requirements.

Movano Health is dedicated to transparency and proactive engagement with its investors and the broader community, ensuring that all updates pertaining to this situation will be communicated thoroughly. For more information regarding Movano Health and its initiatives, please visit Movano Health's official website.

In summary, Movano Health faces a pivotal moment as it works to correct its filing oversight with Nasdaq. The coming weeks are crucial for the company, as they formulate a compliance plan that will determine their standing on the stock exchange and the trust of their shareholders. Simultaneously, Movano Health continues to innovate in the health tech space, committed to its vision of enhancing healthcare solutions through meaningful, data-driven insights.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.